Analyst Research

Report Title Price
Zhejiang CONBA Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Thomson Reuters Stock Report - ZHEJIANG CONBA PHARMACEUTICAL CO., LTD. (600572-SH)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Wright Investors Service Comprehensive Report for Zhejiang Conba Pharmaceutical Co., Ltd.
Provider: Wright Reports
$472.00
Buy
Zhejiang Conba Pharmaceutical Co., Ltd. (600572) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Zhejiang CONBA Pharmaceutical Co., Ltd. to Acquire Equity Shares from Inner Mongolia Yitai Coal Company, Ltd.


Wednesday, 8 Aug 2012 08:00pm EDT 

Zhejiang CONBA Pharmaceutical Co., Ltd. announced that it will acquire an 88% stake in an Inner Mongolia-based pharmaceutical company from Inner Mongolia Yitai Coal Company, Ltd.at RMB 200 million. After that, the Company will hold an 88% stake in the target company. 

Latest Developments for Zhejiang CONBA Pharmaceutical Co Ltd

Latest Key Developments in Pharmaceuticals

Company Quote

Zhejiang CONBA Pharmaceutical Co Ltd
(600572.SS)
13.45
-0.03 -0.22%
17 May 2013